Fact CheckerSign in

NCT06135909Recruiting

CHASE Registry of Patients With Pulmonary Hypertension Receiving Targeted Therapy

CHina Registry for the chAracteristics and Management strategieS of patiEnts With Pulmonary Hypertension Using Targeted Therapy

Source: ClinicalTrials.gov · Last updated 18 Jan 2024 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

CHina Registry for the chAracteristics and Management strategieS of patiEnts With Pulmonary Hypertension Using Targeted Therapy (CHASE Study)

Status (registry)
Recruiting
Study type
Observational
Enrollment
5000 (estimated)
First submitted
12 Nov 2023
Start date
1 Jan 2020
Primary completion date
31 Dec 2027
Lead sponsor
Chinese Pulmonary Vascular Disease Research Group
NCT number
NCT06135909

What you commit to

  • Study type: Observational
  • Planned participants: 5000
  • From 1 Jan 2020 to the primary completion date, 31 Dec 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Have a history of mental illness or drug or poison addiction, and can not sign informed consent or can not cooperate with the experimental study;
  • Patients with malignant tumor and other diseases and life expectancy of less than half a year;
  • Short-term (less than 2 weeks) patients taking targeted drugs for pulmonary hypertension

Who the study is looking for

  • Sign informed consent;
  • Between the ages of 18 and 85;
  • Clinical diagnosis of pulmonary hypertension, using or planning to use pulmonary hypertension targeted drugs (including any one or more of the following: prostacyclin analogues, endothelin receptor antagonists, phosphodiesterase inhibitors, soluble guanylate cyclase agonists and prostacyclin receptor agonists).

Age in the registry: 18 years to 85 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Center for Respiratory and Pulmonary Vascular Diseases, Fuwai hospital, CAMS & PUMC
Coordinator of this site? Confirm its status
BeijingChinaRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.